Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the 2017 Wells Fargo 12th Annual Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the 2017 Wells Fargo 12th Annual Healthcare Conference on Wednesday, Sept. 6, at The Westin Boston...

Key Takeaway: NEW BRUNSWICK, N.J. , Aug. 4, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2017 Wells Fargo 12 th Annual Healthcare Conference on Wednesday, Sept. 6 , at The Westin Boston Waterfront in Boston, MA. Alex Gorsky, Chairman and Chief Executive Officer a

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Aug. 4, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2017 Wells Fargo 12 th Annual Healthcare Conference on Wednesday, Sept. 6 , at The Westin Boston Waterfront in Boston, MA. Alex Gorsky, Chairman and Chief Executive Officer and Dominic Caruso , Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.
Last updated: Aug 4, 2017